Anti-MUC1 139H2 reverse engineering

downstream-application

Anti-MUC1 139H2 reverse engineering: downstream-application. Reverse-engineers the anti-MUC1 antibody 139H2 by mass spectrometry-based de novo sequencing, MUC1 being a mucin whose aberrant expression and glycosylation matter in…

Reverse-engineers the anti-MUC1 antibody 139H2 by mass spectrometry-based de novo sequencing, MUC1 being a mucin whose aberrant expression and glycosylation matter in adenocarcinoma.

Kind	downstream-application
Deep learning	no
Acquisition	DDA
Application area	Antibodyomics

Paper describing it

• Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry–based de novo sequencing (2024, Life Science Alliance, peer-reviewed)

Authors (10)

Weiwei Peng, Koen CAP Giesbers, Marta Šiborová, J Wouter Beugelink, Matti F Pronker, Douwe Schulte, John Hilkens, Bert JC Janssen, Karin Strijbis, Joost Snijder

Seen in the charts

• Application areas
• Models and the authors behind them

Back to the full map